| scholarly article | Q13442814 |
| P356 | DOI | 10.3779/J.ISSN.1009-3419.2010.09.12 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC6000346 |
| https://europepmc.org/articles/PMC6000346?pdf=render | ||
| P932 | PMC publication ID | 6000346 |
| P698 | PubMed publication ID | 20840821 |
| P2093 | author name string | Zhihao Wu | |
| Qinghua Zhou | |||
| Yibing Yao | |||
| P2860 | cites work | p53 autoantibodies predict subsequent development of cancer | Q23924072 |
| Human neoplasms elicit multiple specific immune responses in the autologous host | Q24564371 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Cancer statistics, 2008 | Q27860585 | ||
| Cancer/testis antigens: an expanding family of targets for cancer immunotherapy | Q28215652 | ||
| Using protein microarray as a diagnostic assay for non-small cell lung cancer | Q30796772 | ||
| Profiling tumor-associated antibodies for early detection of non-small cell lung cancer | Q30830942 | ||
| The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells. | Q31018962 | ||
| Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display | Q31038778 | ||
| Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis | Q33227518 | ||
| Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis | Q33232871 | ||
| High throughput proteomic strategies for identifying tumour-associated antigens | Q33274295 | ||
| Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma | Q33323321 | ||
| Discovery of antibody biomarkers using protein microarrays of tumor antigens cloned in high throughput | Q33432976 | ||
| Humoral response to cancer as a tool for biomarker discovery | Q33470783 | ||
| Autoantibodies to tumor-associated antigens as cancer biomarkers. | Q33536109 | ||
| Screening and Identification of Non-Small-Cell Lung Cancer Associated Antigen with SEREX. | Q33662841 | ||
| What is missing in immunology to understand immunity? | Q34023421 | ||
| Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays | Q34705309 | ||
| Influence of p53 on anti-tumor immunity (review). | Q36359976 | ||
| American Cancer Society guidelines for the early detection of cancer, 2006. | Q36383102 | ||
| Immune responses to malignancies | Q37040501 | ||
| Autoantibodies to tumor-associated antigens: reporters from the immune system | Q37118192 | ||
| Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera | Q37119458 | ||
| Protein arrays as tools for serum autoantibody marker discovery in cancer | Q37405637 | ||
| The immune system and cancer | Q37523982 | ||
| Identifying autoantibody signatures in cancer: a promising challenge. | Q37579900 | ||
| The changing epidemiology of lung cancer with a focus on screening | Q37581217 | ||
| p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge. | Q37604767 | ||
| Serum autoantibodies as biomarkers for early cancer detection | Q37622471 | ||
| Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response | Q40072022 | ||
| A proteomic approach to investigate potential biomarkers directed against membrane-associated breast cancer proteins. | Q40301731 | ||
| An efficient proteomics-based approach for the screening of autoantibodies. | Q40417822 | ||
| Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer | Q40770750 | ||
| Serological identification of human tumor antigens | Q41642426 | ||
| Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer | Q46964965 | ||
| Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection. | Q51278201 | ||
| Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. | Q53522277 | ||
| Tumour-specific immunity against spontneous rat tumours | Q72864966 | ||
| Harnessing immunity for cancer marker discovery | Q78745718 | ||
| [New principles in tumor antigens and their significance in future immunotherapies for lymphomas and other malignancies--editorial] | Q79791077 | ||
| Autoantibodies in breast cancer: their use as an aid to early diagnosis | Q79905914 | ||
| Autoantibody biomarker opens a new gateway for cancer diagnosis | Q82578184 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | Chinese | Q7850 |
| P921 | main subject | autoantibody | Q785022 |
| biomarker | Q864574 | ||
| P304 | page(s) | 903-907 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Chinese Journal of Lung Cancer | Q26842043 |
| P478 | volume | 13 |
Search more.